Theory Paper IIDrNB Cardiology – Theory Notes

CARDIAC AMYLOIDOSIS; DEFINITION AND PATHOPHYSIOLOGY

2-page exam answerLast reviewed: October 2026
Merit MedScript seal

IDEFINITION AND CLASSIFICATION

  • Definition: Cardiac Amyloidosis (CA) is an infiltrative, restrictive-phenotype cardiomyopathy caused by the extracellular deposition of insoluble, misfolded autologous protein fibrils arranged in antiparallel beta-pleated sheets within the myocardial interstitium, conduction system, valves, and intramural coronary microvasculature.
  • The Clinical Result: Progressive interstitial expansion and direct proteotoxicity cause biventricular wall thickening (“pseudo-hypertrophy”), profound diastolic stiffness (Restrictive Cardiomyopathy), biatrial enlargement with high thromboembolic risk, heart failure (predominantly HFpEF progressing to low-output systolic failure), and conduction block or arrhythmias.
  • The Two Dominant Precursor Proteins (Greater Than 95 Percent of All Cases):
    • Immunoglobulin Light-Chain (AL) Amyloidosis: Derived from monoclonal lambda (75 to 80 percent) or kappa (20 to 25 percent) free light chains produced by a bone marrow plasma cell clone.
    • Transthyretin (ATTR) Amyloidosis: Derived from misfolded transthyretin (prealbumin) synthesized predominantly (>95 percent) by the liver, subdivided into Wild-Type (ATTRwt) and Hereditary/Variant (ATTRv) disease.
    • Rare Secondary Subtypes (<5 Percent): Serum Amyloid A (AA amyloidosis in chronic inflammatory diseases), Apolipoprotein A-I, isolated atrial amyloidosis (Atrial Natriuretic Peptide [AANP]), and heavy-chain (AH) amyloidosis.

IIPATHOPHYSIOLOGY: MOLECULAR FIBRILLOGENESIS

  • AL Amyloidosis (Clonal Plasma Cell Dyscrasia + Direct Proteotoxicity):
    • Origin: An indolent bone marrow plasma cell clone (or rarely overt multiple myeloma / Waldenström macroglobulinemia) secretes kinetically unstable monoclonal immunoglobulin light chains.
    • Mechanism: Unfolding of the light-chain variable domain exposes hydrophobic residues that self-assemble into soluble prefibrillar oligomers and insoluble cross-beta amyloid fibrils stabilized by Serum Amyloid P (SAP) and glycosaminoglycans in the cardiac extracellular matrix.
    • ATTR Amyloidosis (Tetramer Dissociation as the Rate-Limiting Step):
    • Origin: Native Transthyretin (TTR) is a stable 55-kDa homotetrameric transport protein synthesized by the liver (and in small amounts by the choroid plexus and retinal pigment epithelium) that transports thyroxine (T4) and retinol-binding protein (Vitamin A).
    • Mechanism: Proteolytic cleavage and kinetic/thermodynamic destabilization of the TTR tetramer at the weaker dimer-dimer thyroxine-binding interface cause tetramer dissociation into folded monomers—the rate-limiting step of ATTR fibrillogenesis (and the exact therapeutic target of TTR stabilizers like Tafamidis and Acoramidis). These monomers subsequently misfold and polymerize into insoluble amyloid fibrils.
    • Clinical Subtypes:
    • Wild-Type ATTR (ATTRwt, formerly “Senile Systemic Amyloidosis”): Age-related oxidative modification and chaperone exhaustion cause normal, unmutated wild-type TTR tetramers to dissociate; predominantly affects men over 65 to 70 years of age.
    • Hereditary / Variant ATTR (ATTRv): Autosomal dominant single-point mutations in the TTR gene (chromosome 18) thermodynamically destabilize the tetramer, accelerating dissociation and earlier clinical onset. Key variants include Val122Ile (p.Val142Ile) (present in 3 to 4 percent of African Americans; predominantly cardiopathic), Thr60Ala (p.Thr80Ala) (mixed cardiac and neuropathic), and Val30Met (p.Val50Met) (classic familial amyloid polyneuropathy with conduction disease).
Pathophysiological Feature AL Cardiac Amyloidosis ATTRwt (Wild-Type) Amyloidosis ATTRv (Hereditary) Amyloidosis
Precursor Protein & Source Monoclonal Lambda/Kappa Light Chains (Bone marrow plasma cells) Normal Wild-Type Transthyretin (Liver) Mutant Variant Transthyretin (Liver; autosomal dominant TTR gene)
Myocardial Injury Mechanism Dual Hit: Interstitial fibril infiltration PLUS acute direct light-chain oligomer cardiotoxicity Predominantly chronic mechanical interstitial fibril infiltration (slower progression) Chronic interstitial fibril infiltration (cardiac, neuropathic, or mixed phenotype)
Wall Thickness vs. Severity Moderate LV wall thickening (12–15 mm) with severe rapid HF & high NT-proBNP Marked LV/RV wall thickening (often 16–20+ mm) with more indolent HF progression Variable wall thickening; depends on specific TTR mutation (Val122Ile, Thr60Ala, Val30Met)
Untreated Median Survival Less than 6 months from HF onset (Medical Emergency) 3.5 to 5 years from diagnosis 2.5 to 5 years (worse in Val122Ile than Val30Met)

IIISTRUCTURAL AND HEMODYNAMIC CONSEQUENCES

  • Massive Extracellular Volume (ECV) Expansion (“Pseudo-Hypertrophy”): Unlike true Hypertrophic Cardiomyopathy or hypertensive LVH (where individual cardiomyocytes enlarge), amyloid fibrils accumulate in the extracellular space, expanding the Extracellular Volume (ECV) fraction to 40 to 70 percent (normal 22 to 28 percent). This physically separates, compresses, and atrophies cardiomyocytes—explaining the classic ECG-to-Echo discordance (thick walls on Echo with low QRS voltages on ECG).
  • Restrictive Diastolic Physiology and Steep Pressure-Volume Relationship: The amyloid-stiffened left and right ventricles cannot relax or expand during diastole, shifting the end-diastolic pressure-volume relationship (EDPVR) sharply upward and to the left. Small increases in intravascular volume cause steep spikes in left and right ventricular filling pressures (pulmonary edema and systemic venous congestion), whereas small volume reductions from over-diuresis cause a precipitous drop in Fixed Stroke Volume and blood pressure.
  • Atrial Myopathy and Electromechanical Dissociation: Primary amyloid infiltration of the left and right atrial walls—compounded by chronic restrictive elevation of atrial pressures—leads to biatrial enlargement, loss of atrial reservoir/contractile strain, and “atrial standstill” (electromechanical dissociation), predisposing to left atrial appendage thrombi and cardioembolic stroke even during sinus rhythm.
  • Longitudinal-Before-Radial Systolic Failure (“Apical Sparing” to “Burn-Out”): Subendocardial longitudinal myocardial fibers at the base and mid-ventricle are infiltrated earliest, severely depressing Global Longitudinal Strain (GLS) while relative sparing of the apex (“Cherry-on-Top” pattern) and compensatory radial contraction maintain a “normal” LVEF until late-stage cardiomyocyte strangulation causes LVEF decline, low cardiac output, and spontaneous resolution (“pseudo-cure”) of prior systemic hypertension.

IVCELLULAR PROTEOTOXICITY, CONDUCTION AND MICROVASCULAR INJURY

  • Direct Light-Chain Cardiotoxicity in AL Amyloidosis (The Liao-Falk Mechanism): In AL amyloidosis, circulating soluble prefibrillar light-chain oligomers directly enter cardiomyocytes, impair autophagic-lysosomal flux, and activate the non-canonical p38 Mitogen-Activated Protein Kinase (p38-MAPK) pathway. This generates intense mitochondrial Reactive Oxygen Species (ROS) oxidative stress, impairs intracellular calcium handling, directly suppresses contractility, and induces cardiomyocyte apoptosis (and directly stimulates NPPB gene transcription, explaining why NT-proBNP is disproportionately higher and survival is far shorter in AL than ATTR for the exact same degree of LV wall thickness, and why rapid light-chain clearance with Daratumumab-CyBorD improves cardiac function before physical amyloid fibrils are resorbed).
  • Infiltration of the Cardiac Conduction System and Autonomic Nerves: Amyloid deposition and fibrosis within the Sinoatrial (SA) node, Atrioventricular (AV) node, and infra-Hisian His-Purkinje system produce sinus node dysfunction, bundle branch blocks, and high-degree / Complete AV Block, while infiltration of sympathetic/parasympathetic ganglia causes severe autonomic neuropathy and orthostatic hypotension.
  • Intramural Coronary Microvascular Dysfunction: Perivascular and medial amyloid cuffs surround and narrow intramural coronary arterioles, severely reducing Coronary Flow Reserve (CFR) and causing chronic subendocardial ischemia, angina with normal epicardial coronary arteries, and persistent low-level elevation of high-sensitivity cardiac troponin.

Key references

  • Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 12th Ed., Elsevier, 2022.
  • Garcia-Pavia P, Rapezzi C, Adler Y, et al.: Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases, European Heart Journal, 2021.
  • Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review, Journal of the American College of Cardiology, 2019.
meritmedscript.comDr. Sidhartha Mullapudi

Was this answer useful?

Your rating helps decide which topics to expand next.

Report an error

Spotted something outdated or incorrect? Tell us and we will check it against the source.